(Q67746889)

English

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris

scientific article published on February 15, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectoris (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

author name string

M. L. Sedgwick

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736617

12 November 2022

H. S. Rasmussen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736617

12 November 2022

S. M. Cobbe

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736617

12 November 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

15 February 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1736617

12 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:000291499290996C?httpAccept=text/xml

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

https://api.elsevier.com/content/article/PII:000291499290996C?httpAccept=text/plain

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

513-517

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

2

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium

8

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug

9

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay

11

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

A reference data base for multilead electrocardiographic computer measurement programs

12

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias

14

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Classification and action of antiarrhythmic drugs

15

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Amiodarone kinetics after single i.v. bolus and multiple dosing in healthy volunteers.

16

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers

17

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Torsade de pointes during loading with amiodarone

18

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone

19

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

20

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro

21

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Class III Antiarrhythrnic Action Linked with Positive Inotropy: Effects of the d- and 1-Isomer of Sotalol on Isolated Rat Atria at Threshold and Suprathreshold Stimulation

22

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Cardiodepressive effects of antiarrhythmic drugs

23

1 reference

10.1016/0002-9149(92)90996-C

https://api.crossref.org/works/10.1016/0002-9149(92)90996-C

12 November 2022

Identifiers

10.1016/0002-9149(92)90996-C

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1736617%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67746889&oldid=1769865157"